European Healthtech startup funding raised during April 2021.
In April 2021, 35 European Healthtech companies raised a combined €816M across 35 funding rounds, up 99.4% versus April 2020. Sweden led by capital raised, and RA Capital Management was the most active investor. Data as of 9 Jul 2026.
2 exits.
| €69M |
| Kaia Health | Series D+ | Apr 2021 | €62M |
| Nucleix | Other | Apr 2021 | €47M |
| Current Health | Series B | Apr 2021 | €36M |
| Proximie | Series B | Apr 2021 | €32M |
| Onward | Other | Apr 2021 | €27M |
| Lion (Spiden) | Other | Apr 2021 | €15M |
| Inbrain Neuroelectronics | Series A | Apr 2021 | €14M |
| Rinri Therapeutics | Other | Apr 2021 | €12M |
| Zedsen | Series B | Apr 2021 | €10M |
| Les Opticiens Mobiles | Series B | Apr 2021 | €7.5M |
| Doctify | Other | Apr 2021 | €6.3M |
